M&T Bank Corp Sells 15,646 Shares of Walgreens Boots Alliance, Inc. (WBA)

M&T Bank Corp reduced its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 367,611 shares of the pharmacy operator’s stock after selling 15,646 shares during the period. M&T Bank Corp’s holdings in Walgreens Boots Alliance were worth $28,788,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of WBA. Hudock Capital Group LLC boosted its stake in shares of Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 6 shares during the period. Reilly Financial Advisors LLC boosted its stake in shares of Walgreens Boots Alliance by 7.9% in the second quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock valued at $107,000 after buying an additional 100 shares during the period. Orrstown Financial Services Inc. boosted its stake in shares of Walgreens Boots Alliance by 14.1% in the second quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock valued at $135,000 after buying an additional 213 shares during the period. Private Vista LLC boosted its stake in shares of Walgreens Boots Alliance by 6,403.7% in the second quarter. Private Vista LLC now owns 583,185 shares of the pharmacy operator’s stock valued at $140,000 after buying an additional 574,218 shares during the period. Finally, Hanson McClain Inc. boosted its stake in shares of Walgreens Boots Alliance by 4.6% in the second quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator’s stock valued at $156,000 after buying an additional 87 shares during the period. Institutional investors and hedge funds own 63.58% of the company’s stock.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director John Anthony Lederer purchased 20,000 shares of the business’s stock in a transaction on Thursday, October 26th. The shares were purchased at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the transaction, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The disclosure for this purchase can be found here. Corporate insiders own 13.50% of the company’s stock.

WARNING: “M&T Bank Corp Sells 15,646 Shares of Walgreens Boots Alliance, Inc. (WBA)” was posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece on another site, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this piece can be viewed at https://ledgergazette.com/2017/11/18/mt-bank-corp-sells-15646-shares-of-walgreens-boots-alliance-inc-wba.html.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at $71.25 on Friday. The firm has a market capitalization of $71,980.00, a price-to-earnings ratio of 13.84, a P/E/G ratio of 1.26 and a beta of 1.20. Walgreens Boots Alliance, Inc. has a 1-year low of $63.82 and a 1-year high of $88.00. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.10. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. Walgreens Boots Alliance’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.07 earnings per share. equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 5.55 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a yield of 2.25%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 42.33%.

Walgreens Boots Alliance announced that its Board of Directors has approved a share buyback plan on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to buy shares of its stock through open market purchases. Shares buyback plans are typically a sign that the company’s management believes its stock is undervalued.

Several equities research analysts have weighed in on the company. Morgan Stanley cut Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and cut their target price for the stock from $95.00 to $85.00 in a research note on Friday, October 6th. Robert W. Baird restated an “outperform” rating and set a $80.00 target price (down from $90.00) on shares of Walgreens Boots Alliance in a research note on Thursday, October 19th. They noted that the move was a valuation call. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, August 30th. Zacks Investment Research cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, October 17th. Finally, Needham & Company LLC restated a “buy” rating and set a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Sunday, September 10th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $87.63.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply